News Focus
News Focus
Followers 57
Posts 10479
Boards Moderated 0
Alias Born 09/21/2016

Re: falconer66a post# 325829

Friday, 08/13/2021 6:00:57 PM

Friday, August 13, 2021 6:00:57 PM

Post# of 517757
falconer

The blarcamesine “safety factor” should not be neglected; it’s major.



Thanks again for your ongoing analysis of AVXL CNS treatments. I am also certain that you would be among the first to point out any technical issues or risks. We need you to do that also.

One rule I like to also apply is ..."are there any credible contradictions out in the scientific community to any AVXL claims?" For example we noted the long string of observations for concern or contradictions on Amyloid Plaque. These were routinely ignored by product hypes and even unaccountably (seemingly) by the FDA. (what contradictions???) seemed to be the template. Every device/product contradiction must be evaluated in the open, no matter how obtuse they may seem.

Again, thank you sir for you interest and for your powerful contributions here. IMO, a very valuable aspect for this board is it's intellectual integrity in spirit and in facts.

Let's all keep an eye open for contradictions involving AVXL or involving anything of consequence by a potential competitor.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News